Alvotech

Alvotech showed no cyber incidents or red-flag 8-K filings in our 90-day monitoring window, suggesting operational stability in the near term. However, absence of recent events does not indicate underlying risk—the company's biotech stage, capital structure, and historical financing patterns require deeper analysis. Our 90-day scan captures acute threats only; a fuller risk picture depends on 12-month filing history, shareholder dilution trajectories, and debt refinancing exposure. The full $49 Report adds a dilution risk score, detailed 8-K context going back one year, complete financing history, and AI-detected regulatory and solvency signals.